
USD
+$0.00
(+0.00%
)At Close (As of Nov 28, 2025)
$37.23B
Market Cap
26.1
P/E Ratio
9.77
EPS
$293.11
52 Week High
$198.60
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $3.1B |
| Total Revenue | $5.1B |
| Cost Of Revenue | $2.1B |
| Costof Goods And Services Sold | $2.1B |
| Operating Income | $1.7B |
| Selling General And Administrative | $991M |
| Research And Development | $331M |
| Operating Expenses | $1.4B |
| Investment Income Net | - |
| Net Interest Income | $4.1M |
| Interest Income | $2.5M |
| Interest Expense | $13M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $236M |
| Income Before Tax | $1.7B |
| Income Tax Expense | $277M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $1.4B |
| Comprehensive Income Net Of Tax | - |
| Ebit | $1.7B |
| Ebitda | $1.9B |
| Net Income | $1.4B |
| Field | Value (USD) |
|---|---|
| Total Assets | $8.2B |
| Total Current Assets | $3.5B |
| Cash And Cash Equivalents At Carrying Value | $1.2B |
| Cash And Short Term Investments | $1.2B |
| Inventory | $928M |
| Current Net Receivables | $991M |
| Total Non Current Assets | $4.7B |
| Property Plant Equipment | $718M |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $465M |
| Intangible Assets Excluding Goodwill | $465M |
| Goodwill | $3B |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $13M |
| Other Current Assets | $378M |
| Other Non Current Assets | - |
| Total Liabilities | $2.2B |
| Total Current Liabilities | $1B |
| Current Accounts Payable | $278M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $40M |
| Total Non Current Liabilities | $1.2B |
| Capital Lease Obligations | $184M |
| Long Term Debt | $658M |
| Current Long Term Debt | $9.9M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $852M |
| Other Current Liabilities | $535M |
| Other Non Current Liabilities | $142M |
| Total Shareholder Equity | $6B |
| Treasury Stock | - |
| Retained Earnings | $6.1B |
| Common Stock | $761K |
| Common Stock Shares Outstanding | $147M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $1.8B |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $236M |
| Capital Expenditures | $90M |
| Change In Receivables | - |
| Change In Inventory | -$80M |
| Profit Loss | - |
| Cashflow From Investment | -$200M |
| Cashflow From Financing | -$606M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $311M |
| Dividend Payout Common Stock | $311M |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$300M |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $1.4B |
| Field | Value (USD) |
|---|---|
| Gross Profit | $3.1B |
| Total Revenue | $5.1B |
| Cost Of Revenue | $2.1B |
| Costof Goods And Services Sold | $2.1B |
| Operating Income | $1.7B |
| Selling General And Administrative | $991M |
| Research And Development | $331M |
| Operating Expenses | $1.4B |
| Investment Income Net | - |
| Net Interest Income | $4.1M |
| Interest Income | $2.5M |
| Interest Expense | $13M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $236M |
| Income Before Tax | $1.7B |
| Income Tax Expense | $277M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $1.4B |
| Comprehensive Income Net Of Tax | - |
| Ebit | $1.7B |
| Ebitda | $1.9B |
| Net Income | $1.4B |
| Field | Value |
|---|---|
| Ex Dividend Date | 2025-11-13 |
| Declaration Date | 2025-10-30 |
| Record Date | 2025-11-13 |
| Payment Date | 2025-12-18 |
| Amount | 0.6 |
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
ResMed Inc. (RMD) is a leading healthcare technology company based in San Diego that specializes in cloud-connected devices and software for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. The company is dedicated to elevating patient outcomes through cutting-edge digital health innovations while streamlining clinical effectiveness and operational efficiencies for healthcare providers. As a pioneer in the respiratory care sector, ResMed is well-positioned for significant growth, underpinned by its strategic global market expansion and the rising demand for integrated respiratory solutions among patients worldwide.